Jian Liu
46Patents
6h-index
179Co-inventors
68Inventor score
Filing activity: Mar 31, 2004 → Oct 31, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7608622B2 | Imidazo[4,5-b]pyrazinone inhibitors of protein kinases | Human Necessities | 50 | Active |
| US9981970B2 | Bicyclic ureas and thiadiazolidine-1, 1-dioxides as CETP inhibitors | Chemistry; Metallurgy | 11 | Active |
| US8871738B2 | Fused bicyclic oxazolidinone CETP inhibitor | Human Necessities | 8 | Active |
| US10533037B2 | Freeze-dried powder of high molecular weight silk fibroin, preparation method therefor and use thereof | Human Necessities | 8 | Active |
| US8293900B2 | Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators | Human Necessities | 6 | Active |
| US9718828B2 | BTK Inhibitors | Chemistry; Metallurgy | 6 | Active |
| US7951829B2 | Benzimidazole modulators of VR1 | Chemistry; Metallurgy | 6 | Active |
| US7326788B2 | Quinolinone derivatives as inhibitors of c-fms kinase | Emerging Cross-Sectional Technologies | 4 | Expired |
| US11484565B2 | PCSK9 antagonist compounds | Human Necessities | 1 | Active |
| US9481682B2 | Substituted benzamides and substituted pyridinecarboxamides as Btk inhibitors | Emerging Cross-Sectional Technologies | 1 | Active |
| US8796256B2 | Substituted thiazolidinedione indazoles, indoles and benzotriazoles as estrogen-related receptor-α modulators | Human Necessities | 1 | Active |
| US10246457B2 | Indazole and azaindazole Btk inhibitors | Chemistry; Metallurgy | 1 | Active |
| US7329673B2 | Acylated spiropiperidine derivatives as melanocortin-4 receptor agonists | Chemistry; Metallurgy | 1 | Expired |
| US11427616B2 | PCSK9 antagonist compounds | Human Necessities | 1 | Active |
| US11802122B2 | 2-oxoimidazolidine-4-carboxamides as NAv1.8 inhibitors | Chemistry; Metallurgy | 0 | Active |
| US10214546B2 | Btk inhibitors | Human Necessities | 0 | Active |
| US9446130B2 | BTK inhibitors | Chemistry; Metallurgy | 0 | Active |
| US10947179B2 | 2-(3,4-dihydroxyphenyl)ethyl 3-hydroxybutanoate, composition, and method for improving function of aortic endothelial cell | Chemistry; Metallurgy | 0 | Active |
| US12331044B2 | Inhibitors of histone deacetylase useful for the treatment or prevention of HIV infection | Chemistry; Metallurgy | 0 | Active |
| US10040805B2 | Substituted imidazo[1,5-a]pyrazines as Btk inhibitors | Human Necessities | 0 | Active |
| US8183275B2 | Substituted imidazoles as bombesin receptor subtype-3 modulators | Chemistry; Metallurgy | 0 | Active |
| US8318767B2 | Substituted imidazoles as bombesin receptor subtype-3 modulators | Chemistry; Metallurgy | 0 | Active |
| US12178842B2 | PCSK9 antagonist compounds | Human Necessities | 0 | Active |
| US12365674B2 | Inhibitors of histone deacetylase useful for the treatment or prevention of HIV infection | Chemistry; Metallurgy | 0 | Active |
| US8106070B2 | Substituted imidazoles as bombesin receptor subtype-3 modulators | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.